IRVINE, Calif. - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, has announced a funding round led by ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its ...

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...

For each structural strain of tau fibrils, they identified amino acids without which the strain cannot form its signature ...

Altona reports assay results with 88.03% CaF2 from Monte Muambe. Company advances studies for efficient fluorspar production. Altona Rare Earths Plc has announced promising assay results from its ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, registrational-intent, multicenter Phase 2b trial of ACR-368 in ...